Editor Ben Weinberg

About the Author Editor Ben Weinberg


H.C. Wainwright Reiterates Buy On Spectrum Pharma Following 3Q14 Results

In a research note issued today, H.C.

Oncothyreon Represents An Undervalued Player With Significant Upside, Says H.C. Wainwright

In a research note released today, H.C.

H.C. Wainwright Reiterates Buy On Keryx Following 3Q14 Results

In a research report released today, H.C.

H.C. Wainwright Reiterates Buy On Insmed, Sees 111% Upside For Stock

In a research note released today, H.C.

H.C. Wainwright Reaffirms Buy On Epizyme On The Heels Of Disappointing DOT1L Expansion Data

In a research note published today, H.C.

Shares Of Ariad Are Undervalued And Present Upside, Says H.C. Wainwright

In a research report published today, H.C.

H.C. Wainwright Downgrades Aeterna To Neutral Following CRL From FDA

In a research note published today, H.C.

MLV Maintains Buy On Cytokinetics, Increases PT $9

In a research report released yesterday, MLV analyst George Zavoico¬†upgrades shares of¬†Cytokinetics (NASDAQ:CYTK) from a Hold to a Buy rating and increased his …

Roth Capital Reaffirms Buy On Biolinerx Following Submission Of BL-8040 Protocol Amendment To FDA

In a research report released yesterday, Roth Capital analyst Joseph Pantginis reaffirmed a Buy rating on Biolinerx (NASDAQ:BLRX) with an $8 price target, …

Deutsche Bank Initiates Buy On Shares Of Travelport, Sees 11% Upside For The Stock

In a research note published today, Deutsche Bank analyst Ashish Sabadra initiated a Buy rating on Travelport Worldwide (NYSE:TVPT) with a $17 price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts